GenMark Diagnostics Reports Second Quarter 2012 Results
16:00 EDT 7 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, today
reported financial results for the second quarter ended June 30, 2012.
Revenues for the qua...
Other Sources for this Article
GenMark Diagnostics, Inc.
Hany Massarany
Chief Executive
Officer
760-448-4300
More From BioPortfolio on "GenMark Diagnostics Reports Second Quarter 2012 Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
